| Certificates/Standards: | Not provided |
| Monthly Output: | Not provided |
| Regional: | North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | Not provided |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
Lipa continues to provide cream and gel manufacturing services from its primary site in Minto, but the acquisition of Quest Pharmaceuticals in Melbourne has further enhanced Lipa’s capability and capacity to provide a range of additional cream and gel dosage formats.
Both sites are fully approved to provide a range of cosmetic, listed and registered cream and gel products and increasingly provide our existing customer base with a range of new and innovative product formulations and dosage formats.
The acquisition of the Quest Pharmaceuticals business has enabled Lipa to expand this area of our operations at a substantially faster and more effective manner.
沪公网安备31010402001403号
